Hasten Biopharmaceuticals’ Acquisition of 14 Product Portfolios from Celltrion Healthcare

Freshfields Bruckhaus Deringer (‘Freshfields’) advised Hasten Biopharmaceuticals on the acquisition. Hasten Biopharmaceuticals, a leading specialty pharmaceutical company based in China and a portfolio company of CBC...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Plenty’s $680m JV with Mawarid

Freshfields advised Plenty on its Joint Venture with Mawarid. Plenty Unlimited Inc. (“Plenty”) and Mawarid Holding Investment (“Mawarid”)—a subsidiary of Alpha Dhabi Holding, a major publicly...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

RWE AG’s €5bn Sustainability-Linked Loan

Freshfields Bruckhaus Deringer advised RWE on €5 billion credit with sustainability component. RWE Aktiengesellschaft has successfully concluded a syndicated loan agreement. This new agreement encompasses a...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here